Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
Release Date:
Partner: American College of Emergency Physicians (ACEP)
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Title
Grant Type
Focus Area
Country
Application Due Date
Alopecia Areata (Global)
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology USA
Advancing Health Literacy in The Republic of Ireland
Release Date:
Review Process: Expert Review Panel
Education Support for the Professions Ireland
Education to Improve Antimicrobial Resistance (AMR) Management
Release Date:
Partner: Japanese Society of Chemotherapy
Review Process: Expert Review Panel
Education Hospital Japan
Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Promote the Streamline and Optimization of Healthcare System to Improve Regional Disparities
Release Date:
Partner: Japan Association for Development of Community Medicine
Review Process: Expert Review Panel
Quality Improvement Support for the Professions Japan
Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Establishing Regional Medical Care Coordination System for Detailed examination of the Causes of Heart Failure
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Japan
Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Ulcerative Colitis (UC) Research
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, United Kingdom
Evidence-informed treatment decisions in chronic inflammatory disorders
Release Date:
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Australia